FDA Adverse Event Injury Summary report: N

MEDTRONIC NAVIGATION

MDR report key: 12857278 · Received November 22, 2021

Report

Report Number
1723170-2021-02737
Event Type
Injury
Date Received
November 22, 2021
Date of Event
March 27, 2021
Report Date
November 22, 2021
Manufacturer
MEDTRONIC NAVIGATION, INC
Product Code
HAW
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

PATIENT AGE IS THE MEAN VALUE OF PATIENTS IN THE STUDY. PATIENT GENDER IS THE MAJORITY VALUE OF PATIENTS IN THE STUDY. PATIENT WEIGHT NOT AVAILABLE FROM THE SITE. EVENT DATE IS THE DATE THE ARTICLE WAS ACCEPTED. DEVICE LOT NUMBER, OR SERIAL NUMBER, UNAVAILABLE. 510(K) IS DEPENDENT UPON THE DEVICE MODEL NUMBER AND IS THEREFORE, UNAVAILABLE. NO PARTS HAVE BEEN RECEIVED BY THE MANUFACTURER FOR EVALUATION. DEVICE MANUFACTURE DATE IS DEPENDENT ON THE DEVICE LOT/SERIAL NUMBER, THEREFORE IS UNAVAILABLE. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 0

MARIANI, V., SARTORI, I., REVAY, M., MAI, R., LIZIO, D., BERTA, L., RIZZI, M., COSSU, M. INTRAOPERATIVE CORTICOCORTICAL EVOKED POTENTIALS FOR LANGUAGE MONITORING IN EPILEPSY SURGERY. WORLD NEUROSURGERY. 2021 151: (E109-E121). HTTPS://DOI.ORG/10.1016/J.WNEU.2021.03.1 -OBJECTIVE: TO EVALUATE THE APPLICABILITY OF CORTICOCORTICAL EVOKED POTENTIALS (CCEP) FOR INTRAOPERATIVE MONITORING OF THE LANGUAGE NETWORK IN EPILEPSY SURGERY UNDER GENERAL ANESTHESIA. TO INVESTIGATE THE CLINICAL RELEVANCE ON LANGUAGE FUNCTIONS OF INTRAOPERATIVE CHANGES OF CCEP RECORDED UNDER THESE CONDITIONS. - METHODS: CCEP MONITORING WAS PERFORMED IN 14 EPILEPTIC PATIENTS (6 FEMALES, 4 CHILDREN) DURING RESECTIONS IN THE LEFT PERISYLVIAN REGION UNDER GENERAL ANESTHESIA. ELECTRODE STRIPS WERE PLACED ON THE ANTERIOR LANGUAGE AREA (AL) AND POSTERIOR LANGUAGE AREA (PL), IDENTIFIED BY STRUCTURAL AND FUNCTIONAL MAGNETIC RESONANCE IMAGING. SINGLEPULSE ELECTRIC STIMULATIONS WERE DELIVERED TO PAIRS OF ADJACENT CONTACTS IN A BIPOLAR FASHION. DURING RESECTION, WE MONITORED THE INTEGRITY OF THE DORSAL LANGUAGE PATHWAY BY STIMULATING EITHER AL BY RECORDING CCEP FROM PL OR VICE VERSA, DEPENDING ON STABILITY AND REPRODUCIBILITY OF CCEP. WE EVALUATED THE FIRST NEGATIVE (N1) COMPONENT OF CCEP BEFORE, DURING, AND AFTER RESECTION. - RESULTS: ALL PROCEDURES WERE SUCCESSFULLY COMPLETED WITHOUT ADVERSE EVENTS. THE BEST RESPONSE WAS OBTAINED FROM AL DURING STIMULATION OF PL IN 8 PATIENTS AND FROM PL DURING STIMULATION OF AL IN 6 PATIENTS. NONE OF 12 PATIENTS WITH A POSTRESECTION N1 AMPLITUDE DECREASE OF 0%E15% FROM BASELINE PRESENTED POSTOPERATIVE LANGUAGE IMPAIRMENT. DECREASES OF 28% AND 24%, RESPECTIVELY, OF THE N1 AMPLITUDE WERE OBSERVED IN 2 PATIENTS WHO DEVELOPED TRANSIENT POSTOPERATIVE SPEECH DISTURBANCES. - CONCLUSIONS: THE APPLICATION OF CCEP MONITORING IS POSSIBLE AND SAFE IN EPILEPSY SURGERY UNDER GENERAL ANESTHESIA. PUTATIVE AL AND PL CAN BE IDENTIFIED USING NONINVASIVE PRESURGICAL NEUROIMAGING. DECREASE OF N1 AMPLITUDE >15% FROM BASELINE MAY PREDICT POSTOPERATIVE LANGUAGE DEFICITS. REPORTABLE EVENTS TWO PATIENTS, WHO PRESENTED WITH NORMAL LANGUAGE PERFORMANCES IN THE IMMEDIATE POSTOPERATIVE PERIOD, DEVELOPED LATE RELEVANT LANGUAGE IMPAIRMENT IN THE SUBSEQUENT HOURS, BECAUSE OF OCCURRENCE OF LOCAL HEMORRHAGIC (CASE 9) AND EDEMATOUS (CASE 5) COMPLICATIONS, RESPECTIVELY. RECOVERY OF NORMAL LANGUAGE FUNCTIONS OCCURRED WITHIN 6 MONTHS. THE 2 REMAINING PATIENTS (CASES 1 AND 6) SHOWED IMMEDIATE POSTOPERATIVE SPEECH DISTURBANCES. AT AWAKENING, ONE PATIENT SHOWED PHONEMIC PARAPHASIA AND NAMING IMPAIRMENT. AT CLINICAL FOLLOW-UP, A NORMAL LANGUAGE FUNCTION WAS FULLY RECOVERED 3 MONTHS AFTER DISCHARGE IN CASE 6 THE SYSTEMIC ARTERIAL BLOOD PRESSURE WAS PROGRESSIVELY INCREASED FOR TESTING HEMOSTASIS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1753999 MEDTRONIC NAVIGATION NEUROLOGICAL STEREOTAXIC INSTRUMENT HAW MEDTRONIC NAVIGATION, INC UNK_NAV_SYS

Patients

Seq Age Sex Outcome Treatment
1 25 YR Male Other